Distinguished in Ectopic Cushing's syndrome

Alicja B. Dydejczyk-Hubalewska

Kopernika 17 Str, 
Krakow, MA, PL 
Distinguished in Ectopic Cushing's syndrome
Kopernika 17 Str, 
Krakow, MA, PL 
OverviewLocationsClinical Research

Overview

Alicja Dydejczyk-Hubalewska practices in Krakow, Poland. Ms. Dydejczyk-Hubalewska is rated as a Distinguished expert by MediFind in the treatment of Ectopic Cushing's syndrome. Her top areas of expertise are Ectopic Cushing's syndrome, Neuroendocrine Tumor, Hypothyroidism, Thyroidectomy, and Hormone Replacement Therapy (HRT).

Her clinical research consists of co-authoring 234 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 6 articles in the study of Ectopic Cushing's syndrome.

Gender
Female

Locations

Kopernika 17 Str, Krakow, MA 31501, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Prospective, Randomized, Double-blind, Multi-center Study of the Efficacy and Safety of Lanreotide Autogel®/Depot 120 mg Plus BSC vs. Placebo Plus BSC for Tumour Control in Subjects With Well Differentiated, Metastatic and/or Unresectable, Typical or Atypical, Lung Neuroendocrine Tumours
A Phase 3, Prospective, Randomized, Double-blind, Multi-center Study of the Efficacy and Safety of Lanreotide Autogel®/Depot 120 mg Plus BSC vs. Placebo Plus BSC for Tumour Control in Subjects With Well Differentiated, Metastatic and/or Unresectable, Typical or Atypical, Lung Neuroendocrine Tumours
Enrollment Status: Terminated
Publish Date: July 06, 2022
Intervention Type: Drug
Study Phase: Phase 3

234 Total Publications

Lymphocytic colitis as a new disease possibly associated with autoimmune polyendocrine syndrome type 2 (APS-2).
Lymphocytic colitis as a new disease possibly associated with autoimmune polyendocrine syndrome type 2 (APS-2).
Journal: Endokrynologia Polska
Published: July 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Dydejczyk-Hubalewska's expertise for a condition
ConditionClose
    View All 22 Advanced Conditions
    View All 48 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile